AtriCure has received approval from the Japanese Ministry of Health, Labour and Welfare (MHLW) for its AtriClip products.
“We are excited to bring the AtriClip to Japan,” says Mike Carrel, president and chief executive officer of AtriCure. “This is an important milestone for our growth prospects in the Japanese market, and we are thrilled that we can offer our left atrial appendage (LAA) products to Japanese customers and patients. We see a great opportunity in the Japanese market for this solution, and are looking forward to the launch.”
The company’s distributor in Japan, Century Medical, worked closely with the company to secure approval. In addition, Century Medical will be working closely with the MHLW to secure healthcare insurance system reimbursement for the AtriClip products. Century Medical is the company’s exclusive distributor in Japan under an agreement that runs through 2019.
“We’re pleased to have secured this important approval. We expect that with this technology we will be able to significantly help Japanese patients in the area of LAA occlusion,” says Takahiko Motani, president and CEO of Century Medical.
The approval marks the first time that these products will be available in the Japanese market.